Methods and compositions for activation of sirtuins with Annexin A1 peptides
US10172915B2 · kind B2 · utility
0Cited by
3References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 20, 2014 |
| Grant date | Jan 8, 2019 |
| Priority date | — |
| Expiry date | Feb 22, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1709
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a method of treating, ameliorating or inhibiting sirtuin-associated disorders and/or conditions in a subject in need thereof, by administering to the subject an effective amount of an ANXA1 peptide.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.